Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced

BIOVERIS CORP (BIOV) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/06/2007 4 ROCHE HOLDING LTD (100% Owner) has filed a Form 4 on BIOVERIS CORP
Txns: Bought 1,000 shares @ $21.5, valued at $21.5k
Bought 1,000 preferred shares @ $0
07/06/2007 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/28/2007 4 WOHLSTADTER SAMUEL J (CEO) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 5,027,878 shares @ $21.5, valued at $108.1M
Disposed/sold 1,000 shares @ $0
Disposed/sold 237,559 restricted stock units @ $21.5, valued at $5.1M
Disposed/sold 282,000 options to buy @ $0
Disposed/sold 50,000 options to buy @ $0
06/28/2007 4 SISTERMANS JOOP (Director) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 20,000 shares @ $21.5, valued at $430k
Disposed/sold 16,000 options to buy @ $0
06/28/2007 4 REES ANTHONY R (Director) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 8,600 shares @ $21.5, valued at $184.9k
Disposed/sold 16,000 options to buy @ $0
06/28/2007 4 QUINN JOHN E (Director) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 4,661 shares @ $21.5, valued at $100.2k
Disposed/sold 16,000 options to buy @ $0
06/28/2007 4 MIGAUSKY GEORGE V (CFO) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 134,025 shares @ $21.5, valued at $2.9M
Disposed/sold 6,675 shares @ $21.5, valued at $143.5k
Disposed/sold 316,000 options to buy @ $0
06/28/2007 4 MASSEY RICHARD J (Director) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 1,128,395 shares @ $21.5, valued at $24.3M
Disposed/sold 8,000 options to buy @ $0
06/28/2007 4 CROWLEY WILLIAM J JR (Director) has filed a Form 4 on BIOVERIS CORP
Txns: Disposed/sold 7,338 shares @ $21.5, valued at $157.8k
Disposed/sold 16,000 options to buy @ $0
06/27/2007 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 0% stake in BioVeris Corporation
06/26/2007 8-K Quarterly results
06/21/2007 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 4% stake in BioVeris Corporation
06/18/2007 8-K Other Events
06/14/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/11/2007 SC 13D/A GAMCO INVESTORS, INC. ET AL reports a 3.6% stake in BioVeris Corporation
06/07/2007 10-K Annual Report for the period ended March 31, 2007
06/04/2007 SC 13D GAMCO INVESTORS, INC. ET AL reports a 2.8% stake in BioVeris Corporation
05/21/2007 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
05/18/2007 8-K Entry into a Material Definitive Agreement
05/15/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/10/2007 SC 13D/A ROCHE HOLDING LTD reports a 19.3% stake in 1 )* BioVeris Corporation
05/03/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amended and Restated Stockholders Agreement between Roche Holdings Ltd, Samuel J. Wohlstadter and Nadine Wohlstadter"
04/13/2007 SC 13D ROCHE HOLDING LTD reports a 21.3% stake in BioVeris Corporation
04/10/2007 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger by and among Roche Holding Ltd, Lili Acquisition Corporation and BioVeris Corporation",
"Vaccines Asset Transfer Agreement between BioVeris Corporation and 32 Mott Street Acquisition I, LLC",
"ECL Asset Transfer Agreement between BioVeris Corporation and 32 Mott Street Acquisition II, LLC",
"ECL License Agreement between BioVeris Corporation and 32 Mott Street Acquisition II, LLC",
"Amendment to BioVeris Termination Protection Program",
"BioVeris Severance Plan",
"Non-Disclosure and Non-Solicitation Agreement between BioVeris Corporation and Samuel J. Wohlstadter",
"Transaction Agreement between Samuel J. Wohlstadter and Roche Holding Ltd",
"Stockholders Agreement between Roche Holdings Ltd, Samuel J. Wohlstadter and Nadine Wohlstadter"
04/04/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/04/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "ROCHE TO ACQUIRE BIOVERIS FOR $21.50 PER SHARE"
03/20/2007 SC 13G/A KLEINBERG KAPLAN WOLFF & COHEN P C reports a 8.2% stake in BioVeris Corporation
02/12/2007 SC 13G/A ROYCE & ASSOCIATES LLC reports a 3.4% stake in Bioveris Corporation
02/09/2007 8-K Results of Operations and Financial Condition
Docs: "BIOVERIS REPORTS THIRD QUARTER FISCAL 2007 RESULTS"
02/06/2007 10-Q Quarterly Report for the period ended December 31, 2006
01/26/2007 8-K Other Events
Docs: "BIOVERIS COMPLETES ADDITIONAL VACCINE LICENSE"
01/09/2007 4 MIGAUSKY GEORGE V (CFO) has filed a Form 4 on BIOVERIS CORP
Txns: Gifted 2,000 shares @ $0
Granted 2,000 shares @ $0
01/08/2007 8-K Other Events
Docs: "ROCHE SENDS PRELIMINARY 2004 PAYMENT TO BIOVERIS FOR CERTAIN OUT-OF-FIELD SALES"
12/27/2006 8-K Other Events
Docs: "BIOVERIS COMPLETES NEW VACCINE LICENSE"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy